Dr. Iya Khalil is a technology entrepreneur and theoretical physicist with a vision of transforming medicine and healthcare into a discipline that is quantitative, predictive, and patient-centric via AI and big data. She co-founded two AI and machine learning companies, Gene Network Sciences Inc. and GNS Healthcare, and is the co-inventor of the proprietary AI and machine learning software platform that underpins both entities. Dr. Khalil’s machine learning and AI expertise spans 18 years with applications in drug discovery, drug development, clinical trial optimization, in silico trials, real world evidence and pharmaceutical commercial applications, and all the way to treatment algorithms that can be applied at the point of care. Dr. Khalil has published extensively in AI and machine learning for healthcare, including peer-reviewed journal articles and poster presentations at scientific conferences such as ASCO, AACR, ASH, ISPOR and EASL.
Dr. Khalil is internationally known for her work in AI. She was named to the PharmaVOICE 100 list of the most inspiring people in the life sciences industry for her abilities to build bridges across the life science and healthcare industries, bringing people together to harness the power of computational modeling to change the lives of patients. President Obama in 2014 recognized her as a leading entrepreneur in genomic medicine, was named to Inc’s magazine list of top female founders of 2018 as well as more recently in the Forbes 2019 top women-led startups crushing tech. In 2018 was appointed by Governor Baker to the Massachusetts Center for Health Information and Analysis (CHIA) Oversight Council.